State of Wisconsin Investment Board’s Edgewise Therapeutics EWTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.04M Sell
32,896
-7,101
-18% -$205K ﹤0.01% 1675
2025
Q4
$993K Buy
39,997
+3,378
+9% +$67.8K ﹤0.01% 1686
2025
Q3
$594K Sell
36,619
-17,400
-32% -$247K ﹤0.01% 1801
2025
Q2
$708K Sell
54,019
-17,113
-24% -$247K ﹤0.01% 1714
2025
Q1
$1.56M Buy
71,132
+9,611
+16% +$252K ﹤0.01% 1336
2024
Q4
$1.64M Sell
61,521
-10,263
-14% -$327K ﹤0.01% 1354
2024
Q3
$1.92M Buy
71,784
+20,445
+40% +$407K ﹤0.01% 1325
2024
Q2
$925K Buy
51,339
+31,738
+162% +$554K ﹤0.01% 1584
2024
Q1
$358K Buy
+19,601
New +$312K ﹤0.01% 1898
2022
Q2
Sell
-51,800
Closed -$502K 2835
2022
Q1
$502K Buy
51,800
+35,800
+224% +$461K ﹤0.01% 1883
2021
Q4
$244K Hold
16,000
﹤0.01% 2055
2021
Q3
$266K Buy
+16,000
New +$289K ﹤0.01% 2006

Other funds holding EWTX

State of Wisconsin Investment Board's EWTX Position: Q1 2026 in Review

State of Wisconsin Investment Board reduced its Edgewise Therapeutics (EWTX) stake by 18% in Q1 2026, selling an estimated $205K and leaving 32,896 shares worth $1.04M. The position accounts for ﹤0.01% of the portfolio, ranked #1675.

State of Wisconsin Investment Board first reported a position in EWTX in Q3 2021 and has held it in 12 quarters since. The position peaked at $1.92M in Q3 2024. 214 funds tracked by Wall St. Rank hold EWTX as of Q1 2026.

  • State of Wisconsin Investment Board held 32,896 shares of Edgewise Therapeutics worth $1.04M as of Q1 2026.
  • State of Wisconsin Investment Board sold 7,101 Edgewise Therapeutics shares in Q1 2026, an estimated $205K.
  • Edgewise Therapeutics made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #1675 holding.
  • State of Wisconsin Investment Board first reported a position in Edgewise Therapeutics in Q3 2021 and has held it in 12 quarters since.
  • State of Wisconsin Investment Board's Edgewise Therapeutics position peaked at $1.92M in Q3 2024.
  • 214 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.